Vida raises $11M to commercialize AI lung software

By staff writers

March 12, 2020 -- Lung imaging software developer Vida Diagnostics has raised $11 million to help with the commercialization of its artificial intelligence (AI)-powered lung analysis software, LungPrint.

First Analysis Corporation led the funding round, with equity participation from Blue Heron Capital and UnityPoint Health Ventures. The company also received support from NextLevel Ventures, Chartline Capital Partners, Rural Vitality Fund, Rittenhouse Ventures, Iowa First Capital Fund, and the Angels' Forum.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking